| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 05/16/2000 | CA2157358C Purification of human interleukin-10 |
| 05/16/2000 | CA2131826C Mn gene and protein |
| 05/16/2000 | CA2129969C Dna encoding 5-ht4 serotonin receptors and uses thereof |
| 05/16/2000 | CA2113660C Process for the obtention of biological adhesive made of concentrated coagulation factors by salting-out |
| 05/16/2000 | CA2097820C Proteoglycan(g009) effective in enhancing antitumor immunity |
| 05/16/2000 | CA2090701C Solubilization of proteins in active forms |
| 05/16/2000 | CA2090033C Conjugated moieties for chelating paramagnetic metals |
| 05/16/2000 | CA2084060C Combined treatment with gnrh antagonist and gnrh to control gonadotropin levels in mammals |
| 05/16/2000 | CA1340992C Process for the production of recombinant porcine growth hormone polypeptides |
| 05/12/2000 | CA2288680A1 Modulation of cell proliferative disorders by cyclic rgd |
| 05/11/2000 | WO2000026634A2 Compositions and methods for screening agents that inhibit mapk mediated anti-apoptotic signals |
| 05/11/2000 | WO2000026418A1 Human pan-hcv human monoclonal antibodies |
| 05/11/2000 | WO2000026416A1 Reference clones and sequences for non-subtype b isolates of human immunodeficiency virus type 1 |
| 05/11/2000 | WO2000026407A1 Method for determining cancer by determining expression of mage-10 |
| 05/11/2000 | WO2000026392A2 MUTANT MOUSE CONTAINING A KNOCKOUT MUTATION IN DNA ENCODING AN ENDOGENOUS α4 SUBUNIT OF NICOTINIC ACETYLCHOLINE RECEPTOR |
| 05/11/2000 | WO2000026391A2 Trans-species transfer of apoptotic genes and transgenic plants developed thereby |
| 05/11/2000 | WO2000026389A2 Dna comprising rice anther-specific gene and transgenic plant transformed therewith |
| 05/11/2000 | WO2000026388A2 Novel expression cassette for expressing genes in plant seed |
| 05/11/2000 | WO2000026387A1 Vector for the transformation of phaffia rhodozyma and process of transformation thereby |
| 05/11/2000 | WO2000026385A1 Nucleic acid constructs for genetic immunization |
| 05/11/2000 | WO2000026380A1 Rotavirus subunit vaccine |
| 05/11/2000 | WO2000026379A2 Polypeptide mediating cell permeability |
| 05/11/2000 | WO2000026378A1 POLYPEPTIDE COMPOSITIONS TOXIC TO DIABROTICA INSECTS, OBTAINED FROM BACILLUS THURINGIENSIS; CryET70, AND METHODS OF USE |
| 05/11/2000 | WO2000026377A1 POLYNUCLEOTIDES AND POLYPEPTIDES ENCODING metK ISOLATED FROM $i(STREPTOCCOCCUS PNEUMONIAE) |
| 05/11/2000 | WO2000026376A1 Chlamydia antigens and corresponding dna fragments and uses thereof |
| 05/11/2000 | WO2000026375A2 Nucleic acids and polypeptides specific of the neisseria genus pathogenic strains |
| 05/11/2000 | WO2000026374A2 Adipose specific protein |
| 05/11/2000 | WO2000026372A1 Myosin heavy chain homolog |
| 05/11/2000 | WO2000026371A1 Methods for transforming plants to express bacillus thuringiensis delta-endotoxins |
| 05/11/2000 | WO2000026370A2 Adenine nucleotide translocator (ant) fusion proteins and uses thereof |
| 05/11/2000 | WO2000026369A1 Isolated vshk-1 receptor polypeptides and methods of use thereof |
| 05/11/2000 | WO2000026368A2 Therapeutic antiangiogenic endostatin compositions |
| 05/11/2000 | WO2000026367A2 Therapeutics and diagnostics for ocular abnormalities |
| 05/11/2000 | WO2000026366A1 Isolated nucleic acids encoding a secretory signal for expression and secretion of heterologous recombinant proteins |
| 05/11/2000 | WO2000026365A1 NOVEL GENE AND PROTEIN ERRη ENCODED THEREBY |
| 05/11/2000 | WO2000026364A1 Regulator of notch signaling activity |
| 05/11/2000 | WO2000026363A1 GENOMIC AND COMPLETE cDNA SEQUENCES OF HUMAN ADIPOCYTE-SPECIFIC APM1 AND BIALLELIC MARKERS THEREOF |
| 05/11/2000 | WO2000026362A2 Proteins of the stomatin family and their use as target proteins for pain therapy |
| 05/11/2000 | WO2000026361A1 New protein associated with leptin receptor for obesity and the encoding sequence thereof and the methods for producing same and the uses of the same |
| 05/11/2000 | WO2000026360A1 Compounds and methods for modulating claudin-mediated functions |
| 05/11/2000 | WO2000026359A1 ftsX |
| 05/11/2000 | WO2000026357A2 Transgenic and cloned mammals |
| 05/11/2000 | WO2000026344A1 Peptides with enhanced stability to protease degradation |
| 05/11/2000 | WO2000026343A2 Tissue specific promoters and transgenic animals for the screening of pharmaceuticals |
| 05/11/2000 | WO2000026340A2 Novel nucleic acid molecules encoding opioid growth factor receptors |
| 05/11/2000 | WO2000026339A2 Axor14, a g-protein coupled receptor |
| 05/11/2000 | WO2000026253A1 Human potassium channel (h-traak) |
| 05/11/2000 | WO2000026251A2 A COMPLEX OF A CHAPERONE WITH ss-AMYLOID AND METHODS EMPLOYING THIS COMPLEX |
| 05/11/2000 | WO2000026250A1 HUMAN H37 PROTEINS AND cDNAS ENCODING THE SAME |
| 05/11/2000 | WO2000026249A1 Immunotherapeutic methods using epitopes of wt-1 and gata-1 |
| 05/11/2000 | WO2000026248A2 Tuberculosis diagnostic test |
| 05/11/2000 | WO2000026247A2 Ikaros isoforms and mutants |
| 05/11/2000 | WO2000026246A2 Crystallized form of fc epsilon receptor alpha chain, its 3-d model and uses thereof |
| 05/11/2000 | WO2000026245A2 Human membrane transport proteins |
| 05/11/2000 | WO2000026244A2 A novel tumor necrosis factor family member, drl, and related compositions and methods |
| 05/11/2000 | WO2000026243A2 Transmembrane 4 proteins |
| 05/11/2000 | WO2000026242A2 Dna replication-regulating genes, antibodies thereto and diagnostic applications thereof |
| 05/11/2000 | WO2000026241A2 Novel compositions and methods of screening for t-cell and b-cell activation modulators |
| 05/11/2000 | WO2000026240A2 Streptococcal alpha2m-binding protein |
| 05/11/2000 | WO2000026239A2 $i(chlamydia) antigens and corresponding dna fragments and uses thereof |
| 05/11/2000 | WO2000026238A2 Biological materials and methods useful in the diagnosis and treatment of prion diseases |
| 05/11/2000 | WO2000026237A2 Chlamydia 98kd putative outer membrane protein and corresponding dna fragments and uses thereof |
| 05/11/2000 | WO2000026236A2 Method of modulating cell differentiation or neoplastic transformation by altering cadherin-11 expression or function |
| 05/11/2000 | WO2000026232A1 Repressor of estrogen receptor activity |
| 05/11/2000 | WO2000026231A1 Lymphoma associated molecules and uses therefor |
| 05/11/2000 | WO2000026228A1 Gene and protein for regulation of cell death |
| 05/11/2000 | WO2000026227A1 Ldl related protein and uses thereof |
| 05/11/2000 | WO2000025827A2 Dna molecules encoding muc-1 and use thereof in tumor vaccination |
| 05/11/2000 | WO2000025818A1 asuE/trmU |
| 05/11/2000 | WO2000025815A1 Novel immunoadjuvants |
| 05/11/2000 | WO2000025814A2 Component for vaccine against serogroup b meningococci |
| 05/11/2000 | WO2000025811A2 Multicomponent meningococcal vaccine |
| 05/11/2000 | WO2000025805A1 Vascular endothelial growth factor-like protein from orf virus nz2 binds and activates mammalian vegf receptor-2 |
| 05/11/2000 | WO2000025804A2 A method for inhibition of phospholamban activity for the treatment of cardiac disease and heart failure |
| 05/11/2000 | WO2000025728A2 Chromosome 2 sequence of the human malaria parasite plasmodium falciparum and proteins of said chromosome useful in anti-malarial vaccines and diagnostic reagents |
| 05/11/2000 | WO2000025725A2 Functional antagonists of hedgehog activity |
| 05/11/2000 | WO2000025722A2 ENHANCED VACCINES COMPRISING SELF AND NON-SELF IgE PORTIONS OR DIMERIC ANTIGENS |
| 05/11/2000 | WO2000025696A1 Interactive dental restorative network |
| 05/11/2000 | WO2000025583A1 Recombinant keratinocytes and use thereof |
| 05/11/2000 | WO2000025578A2 Methods for cloning animals |
| 05/11/2000 | WO2000018783B1 Mammaglobin, a secreted mammary-specific breast cancer protein |
| 05/11/2000 | WO2000017344A8 RESPONSE REGULATOR $i(CaSSK1) |
| 05/11/2000 | WO2000017234A8 Purification of fibrinogen from milk by use of cation exchange chromatography |
| 05/11/2000 | WO2000012710A8 Nucleic acids encoding ataxin-2 binding proteins, products related thereto and methods of using same |
| 05/11/2000 | WO2000009691A3 Bpc-1: a secreted brain specific protein expressed and secreted by prostate and bladder cancer cells |
| 05/11/2000 | WO2000008189A3 Plant resistance gene |
| 05/11/2000 | WO2000008164A3 Thermostable in vitro complex with polymerase activity |
| 05/11/2000 | WO2000008159A3 Production and use of modified cystatins |
| 05/11/2000 | WO2000008158A3 Molecules designated ldcam |
| 05/11/2000 | WO2000008156A3 Dna replication- and repair-associated proteins |
| 05/11/2000 | WO2000008146A3 Novel tension-dependent potassium channel and the use thereof in the development of new therapeutic agents |
| 05/11/2000 | WO2000008043A3 Prevention and treatment of viral disease |
| 05/11/2000 | WO2000007618A3 Anti-apoptotic compositions comprising the r1 subunit of herpes simplex virus ribonucleotide reductase or its n-terminal portion; and uses thereof |
| 05/11/2000 | WO2000006087A3 Uncoupling protein-2(hcp2): compositions and methods of use |
| 05/11/2000 | WO2000001712A3 Chemically modified proteins with a carbohydrate moiety |
| 05/11/2000 | WO1999066956A9 IMMUNOLOGICAL AGENTS SPECIFIC FOR PRION PROTEIN (PrP) |
| 05/11/2000 | WO1999054460A3 Human nucleic acid sequences of normal bladder tissue |
| 05/11/2000 | WO1999027100A9 Fibroblast growth factor-19 |
| 05/11/2000 | DE19851675A1 Menschliche Interleukin-10 Mutantenproteine Human interleukin-10 mutant proteins |
| 05/11/2000 | DE19847364C1 Tumor-Protein Tumor protein |